Moderna | MRNA - Bienes





Bienes Cambio Fecha
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amgen USD 95.64B 3.14B 2026-06
Arrowhead Research USD 2.11B 156.25M 2026-06
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Celltrion KRW 779.18B 10.37B 2026-06
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
Incyte USD 7.29B 585.39M 2026-09
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Kangmei Pharma CNY 13.07B 239.31M 2026-06
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Moderna USD 10.96B 527M 2026-06
Organigram Holdings CAD 820.26M 298.95M 2026-06
Ovoca Bio EUR 2.07M 414K 2025-12
Pharma Mar EUR 408.4M 14.8M 2026-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Qiagen NV USD 5.89B 107.14M 2026-06
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
Sartorius EUR 9.67B 70.9M 2026-09
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tilray USD 2.1B 15.95M 2025-09
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09
Zealand Pharma A/S 15.3B 647.8M 2026-03
Zz Pientze Pharmaceu CNY 17.71B 799.05M 2026-09